Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLL6: FCM +/- G-CSF in Relapsed CLL
NCT00416910Phase 3Terminated
- Sponsor
- German CLL Study Group
- Start
- Jul 1999
- Primary completion
- Sep 2003
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of filgrastim in chronic lymphocytic leukemia (CLL), sponsored by German CLL Study Group. Started Jul 1999; status: terminated.
02
Drugs
filgrastim
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00416910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416910.